Dual Regulation of Cell Proliferation and Survival via Activation of Glucagon-Like Peptide-2 Receptor Signaling

Journal of Nutrition

Volumn 133, Issue 11, 2003, Pages 3708-3711

  Estall, Jennifer L ^a   Drucker, Daniel J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Apoptosis; Glucagon like peptide 2; GPCR; Intestine

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 2; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONFERENCE PAPER; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOCRINE CELL; GASTROINTESTINAL MUCOSA; HORMONE RELEASE; HUMAN; INGESTION; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE CRYPT; INTESTINE INJURY; NONHUMAN; NUTRITIONAL STATUS; PROTEIN EXPRESSION; REGENERATION; SIGNAL TRANSDUCTION;

EID: 0242492635     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.11.3708     Document Type: Conference Paper

References (62)

1. Dhanvantari, S., Seidah, N. G. & Brubaker, P. L. (1996) Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol. Endocrinol. 10: 342-355.
2. Dhanvantari, S. & Brubaker, P. L. (1998) Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion. Endocrinology 139: 1630-1637.
3. Tucker, J. D., Dhanvantari, S. & Brubaker, P. L. (1996) Proglucagon processing in islet and intestinal cell lines. Regul. Pept. 62: 29-35.
4. Orskov, C., Holst, J. J., Poulsen, S. S. & Kirkegaard, P. (1987) Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30: 874-881.
5. Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L. & Habener, J. F. (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J. Biol. Chem. 261: 11880-11889.
6. Brubaker, P. L., Crivici, A., Izzo, A., Ehrlich, P., Tsai, C. H. & Drucker, D. J. (1997) Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2. Endocrinology 138: 4837-4843.
7. Xiao, Q., Boushey, R. P., Drucker, D. J. & Brubaker, P. L. (1999) Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117: 99-105.
8. Hartmann, B., Johnsen, A. H., Orskov, C., Adelhorst, K., Thim, L. & Holst, J. J. (2000) Structure, measurement, and secretion of human glucagon-like peptide-2. Peptides 21: 73-80.
9. Drucker, D. J., Shi, Q., Crivici, A., Sumner-Smith, M., Tavares, W., Hill, M., DeForest, L., Cooper, S. & Brubaker, P. L. (1997) Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat. Biotechnol. 15: 673-677.
10. Hartmann, B., Harr, M. B., Jeppesen, P. B., Wojdemann, M., Deacon, C. F., Mortensen, P. B. & Holst, J. J. (2000) In vivo and in vitro degradation of glucagon-like peptide-2 in humans. J. Clin. Endocrinol. Metab. 85: 2884-2888.
11. Ruiz-Grande, C., Pintado, J., Alarcon, C., Castilla, C., Valverde, I. & Lopez-Novoa, J.M. (1990) Renal catabolism of human glucagon-like peptides 1 and 2. Can. J. Physiol. Pharmacol. 68: 1568-1573.
12. Tavares, W., Drucker, D. J. & Brubaker, P. L. (2000) Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats. Am. J. Physiol. Endocrinol. Metab. 278: E134-E139.
13. Stevens, F. M., Flanagan, R. W., O'Gorman, D. & Buchanan, K. D. (1984) Glucagonoma syndrome demonstrating giant duodenal villi. Gut 25: 784-791.
14. Gleeson, M. H., Bloom, S. R., Polak, J. M., Henry, K. & Dowling, R. H. (1971) Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut 12: 773-782.
15. Byrne, M. M., McGregor, G. P., Barth, P., Rothmund, M., Goke, B. & Arnold, R. (2001) Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma. Digestion 63: 61-68.
16. Drucker, D. J., Erlich, P., Asa, S. L. & Brubaker, P. L. (1996) Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl. Acad. Sci. USA 93: 7911-7916.
17. Brubaker, P. L., Izzo, A., Hill, M. & Drucker, D. J. (1997) Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am. J. Physiol. 272: E1050-E1058.
18. Benjamin, M. A., McKay, D. M., Yang, P. C., Cameron, H. & Perdue, M. H. (2000) Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 47: 112-119.
19. Ghatei, M. A., Goodlad, R. A., Taheri, S., Mandir, N., Brynes, A. E., Jordinson, M. & Bloom, S. R. (2001) Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. Dig. Dis. Sci. 46: 1255-1263.
20. Cheeseman, C. I. & O'Neill, D. (1998) Basolateral D-glucose transport activity along the crypt-villus axis in rat jejunum and upregulation induced by gastric inhibitory peptide and glucagon-like peptide-2. Exp. Physiol. 83: 605-616.
21. Kato, Y., Yu, D. & Schwartz, M. Z. (1999) Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo. J. Pediatr. Surg. 34: 18-20; discussion 20-21.
22. Wojdemann, M., Wettergren, A., Hartmann, B. & Holst, J. J. (1998) Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand. J. Gastroenterol. 33: 828-832.
23. Brubaker, P. L., Drucker, D. J., Asa, S. L., Swallow, C., Redston, M. & Greenberg, G. R. (2002) Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor. J. Clin. Endocrinol. Metab. 87: 3078-3083.
24. Cheeseman, C. I. (1997) Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am. J. Physiol. 273: R1965-R1971.
25. Cheeseman, C. I. & Tsang, R. (1996) The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport. Am. J. Physiol. 271: G477-G482.
26. Petersen, Y. M., Elnif, J., Schmidt, M. & Sangild, P. T. (2002) Glucagon-like peptide 2 enhances maltase-glucoamylase and sucrase-isomaltase gene expression and activity in parenterally fed premature neonatal piglets. Pediatr. Res. 52: 498-503.
27. Wojdemann, M., Wettergren, A., Hartmann, B., Hilsted, L. & Holst, J. J. (1999) Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J. Clin. Endocrinol. Metab. 84: 2513-2517.
28. Drucker, D. J., DeForest, L. & Brubaker, P. L. (1997) Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. Am. J. Physiol. 273: G1252-G1262.
29. Thulesen, J., Knudsen, L. B., Hartmann, B., Hastrup, S., Kissow, H., Jeppesen, P. B., Orskov, C., Holst, J. J. & Poulsen, S. S. (2002) The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist. Regul. Pept. 103: 9-15.
30. Fischer, K. D., Dhanvantari, S., Drucker, D. J. & Brubaker, P. L. (1997) Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Am. J. Physiol. 273: E815-E820.
31. Hartmann, B., Thulesen, J., Hare, K. J., Kissow, H., Orskov, C., Poulsen, S. S. & Holst, J. J. (2002) Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats. Regul. Pept. 105: 173-179.
32. Dahly, E. M., Gillingham, M. B., Guo, Z., Murali, S. G., Nelson, D. W., Holst, J. J. & Ney, D. M. (2003) Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection. Am. J. Physiol. Gastrointest. Liver. Physiol. 284: G670-G682.
33. Petersen, Y. M., Burrin, D. G. & Sangild, P. T. (2001) GLP-2 has differential effects on small intestine growth and function in fetal and neonatal pigs. Am. J Physiol. Regul. Integr. Comp. Physiol. 281: R1986-R1993.
34. Tang-Christensen, M., Larsen, P. J., Thulesen, J., Romer, J. & Vrang, N. (2000) The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat. Med. 6: 802-807.
35. Lovshin, J., Estall, J., Yusta, B., Brown, T. J. & Drucker, D. J. (2001) Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J. Biol. Chem. 276: 21489-21499.
36. Tsai, C. H., Hill, M., Asa, S. L., Brubaker, P. L. & Drucker, D. J. (1997) Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am. J. Physiol. 273: E77-E84.
37. Hartmann, B., Thulesen, J., Kissow, H., Thulesen, S., Orskov, C., Ropke, C., Poulsen, S. S. & Holst, J. J. (2000) Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology 141: 4013-4020.
38. Litvak, D. A., Hellmich, M. R., Evers, B. M., Banker, N. A. & Townsend, C. M., Jr. (1998) Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. J. Gastrointest. Surg. 2: 146-150.
39. Yusta, B., Huang, L., Munroe, D., Wolff, G., Fantaske, R., Sharma, S., Demchyshyn, L., Asa, S. L. & Drucker, D. J. (2000) Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119: 744-755.
40. Bjerknes, M. & Cheng, H. (2001) Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc. Natl. Acad. Sci. USA 98: 12497-12502.
41. Guan, X., Stoll, B., Lu, X., Tappenden, K. A., Holst, J. J., Hartmann, B. & Burrin, D. G. (2003) GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1. Gastroenterology 125: 136-147.
42. Jasleen, J., Shimoda, N., Shen, E. R., Tavakkolizadeh, A., Whang, E. E., Jacobs, D. O., Zinner, M. J. & Ashley, S. W. (2000) Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation. J. Surg. Res. 90: 13-18.
43. Jasleen, J., Ashley, S. W., Shimoda, N., Zinner, M. J. & Whang, E. E. (2002) Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro. Dig. Dis. Sci. 47: 1135-1140.
44. Yusta, B., Somwar, R., Wang, F., Munroe, D., Grinstein, S., Klip, A. & Drucker, D. J. (1999) Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor. J. Biol. Chem. 274: 30459-30467.
45. Velazquez, E., Ruiz-Albusac, J. M. & Blazquez, E. (2003) Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes. Eur. J. Biochem. 270: 3001-3009.
46. Drucker, D. J., Yusta, B., Boushey, R. P., DeForest, L. & Brubaker, P. L. (1999) Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am. J. Physiol. 276: G79-G91.
47. Boushey, R. P., Yusta, B. & Drucker, D. J. (1999) Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am. J. Physiol. 277: E937-E947.
48. Boushey, R. P., Yusta, B. & Drucker, D. J. (2001) Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Cancer Res. 61: 687-693.
49. Chance, W. T., Foley-Nelson, T., Thomas, I. & Balasubramaniam, A. (1997) Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. Am. J. Physiol. 273: G559-G563.
50. Chance, W. T., Sheriff, S., Foley-Nelson, T., Thomas, I. & Balasubramaniam, A. (2000) Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: effects of glucagon-like peptide 2. Nutr. Cancer 37: 215-222.
51. Burrin, D. G., Stoll, B., Jiang, R., Petersen, Y., Elnif, J., Buddington, R. K., Schmidt, M., Holst, J. J., Hartmann, B. & Sangild, P. T. (2000) GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G1249-G1256.
52. Munroe, D. G., Gupta, A. K., Kooshesh, F., Vyas, T. B., Rizkalla, G., Wang, H., Demchyshyn, L., Yang, Z. J., Kamboj, R. K., Chen, H., McCallum, K., Sumner-Smith, M., Drucker, D. J. & Crivici, A. (1999) Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc. Natl. Acad. Sci. USA 96: 1569-1573.
53. Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Goke, B., Thorens, B. & Drucker, D. J. (2003) International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev. 55: 167-194.
54. Yusta, B., Boushey, R. P. & Drucker, D. J. (2000) The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway. J. Biol. Chem. 275: 35345-35352.
55. Yusta, B., Estall, J. & Drucker, D. J. (2002) Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 277: 24896-24906.
56. Kouris, G. J., Liu, Q., Rossi, H., Djuricin, G., Gattuso, P., Nathan, C., Weinstein, R. A. & Prinz, R. A. (2001) The effect of glucagon-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis. Am. J. Surg. 181: 571-575.
57. Chance, W. T., Sheriff, S., McCarter, F. & Ogle, C. (2001) Glucagon-like peptide-2 stimulates gut mucosal growth and immune response in burned rats. J. Bum Care Rehabil. 22: 136-143.
58. Rajeevprasad, R., Alavi, K. & Schwartz, M. Z. (2000) Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury. J. Pediatr. Surg. 35: 1537-1539.
59. Alavi, K., Schwartz, M. Z., Palazzo, J. P. & Prasad, R. (2000) Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. J. Pediatr. Surg. 35: 847-851.
60. Tavakkolizadeh, A., Shen, R., Abraham, P., Kormi, N., Seifert, P., Edelman, E. R., Jacobs, D. O., Zinner, M. J., Ashley, S. W. & Whang, E. E. (2000) Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. J. Surg. Res. 91: 77-82.
61. Jeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, J. J. & Mortensen, P. S. (2001) Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120: 806-815.
62. Haderslev, K. V., Jeppesen, P. B., Hartmann, B., Thulesen, J., Sorensen, H. A., Graff, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, J. J., Staun, M. & Mortensen, P. B. (2002) Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand. J. Gastroenterology 37: 392-398.